CNS Minimal Disease Therapy in Childhood Leukaemia
Author Information
Author(s): O.B. Eden
Primary Institution: Royal Hospital for Sick Children
Hypothesis
Can presymptomatic CNS irradiation reduce the incidence of CNS relapse in childhood leukaemia?
Conclusion
Presymptomatic CNS irradiation can significantly reduce overt CNS relapse rates in children with leukaemia.
Supporting Evidence
- Presymptomatic CNS irradiation reduced overt CNS relapse to less than 10%.
- Children receiving craniospinal irradiation had a higher remission rate compared to those treated at the time of overt relapse.
- Long-term follow-up is necessary to assess the full impact of CNS disease on survival.
Takeaway
Doctors are trying to find the best way to treat kids with leukaemia to stop it from coming back in the brain, and using radiation before symptoms show can help a lot.
Methodology
The article reviews various studies comparing the effectiveness of cranial irradiation and intrathecal methotrexate in preventing CNS relapse in childhood leukaemia.
Potential Biases
The review is not based on randomized concurrent trials, which may introduce bias.
Limitations
The studies reviewed have varying follow-up times and methodologies, which may affect the reliability of the conclusions.
Participant Demographics
Children with acute lymphoblastic leukaemia, with varying initial white blood cell counts.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website